+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID05816226

Comparing Topical 2.5% Hydrocortisone and 1% Diclofenac Creams for TMJ Pain Relief and Jaw Function Improvement

Led by University of the Pacific · Updated on 2024-12-11

90

Participants Needed

1

Research Sites

12 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness of topical 2.5% hydrocortisone compared to topical 1% diclofenac in treating temporomandibular joint TMJ arthralgia, which is pain in the jaw joint. The study aims to answer how these treatments compare in reducing pain, improving jaw function, and causing side effects. This is a randomized, phase 3 clinical trial sponsored by the University of the Pacific. Participants will apply either hydrocortisone 2.5% cream or diclofenac 1% cream to the affected TMJ area four times a day for 21 days. On the first day, participants will be examined, and their pain levels and jaw function limitations recorded. They will continue applying the cream for three weeks, with periodic reminders to maintain adherence. On day 21, participants will report their pain, jaw function, compliance, and any side effects experienced. During the study, researchers will collect data through questionnaires and monitor participant adherence with reminders by email and phone calls. Data will be anonymized and analyzed to compare the treatments effects on pain intensity, jaw function limitation, and side effects. The main outcomes are pain and jaw function changes measured on days 1 and 21, with side effects reported on day 21. Participants are involved for a total of 21 days of treatment and follow-up.

CONDITIONS

Brief Title

Topical Treatment for TMJ Arthralgia

Research Team

A

Andrew Young, DDS, MSD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here